Skip To Main Content
Anna Edney on Muck Rack

Anna Edney

Verified
Washington, D.C.
As seen in: Bloomberg News, UOL Economia, MSN, MSN Singapore, UOL, Bloomberg Businessweek, Bloomberg Green Daily, Bloomberg Markets Magazine, ET Healthworld, The Economic Times, The Washington Post and
National health care reporter for Bloomberg News. Of course, tweets are my own, RTs are not endorsements.

Get in touch with Anna

Contact Anna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

研究顯示中國批准的抗癌新藥數量超過美國

|
By Anna Edney Verified
| Yahoo! Finance Hong Kong Verified
Health Affairs 【彭博】-- 周一發表的一項研究顯示，過去幾年，中國藥品監管部門批准上市的抗癌新藥數量超過美國監管機構。該研究表明，對中國生物科技行業的投資正在提升其全球競爭力。 2020年至2025年間，中國國家藥品監督管理局共批准94款新型腫瘤藥上市，而美國食品藥品監督管理局同期批准87款。這項發表於《Health Affairs》期刊的研究顯示，2025年，中國批准的抗癌藥數量接近美國的三倍。該研究由賓夕法尼亞大學和倡導組織Friends of Cancer Research的研究人員完成。 數據顯示，在研究覆蓋時段內，2020年至2022年，美國食品藥品監督管理局批准的藥物數量均高於中國，但這一局面在2023年發生逆轉，此後至2025年中國一直領先美國。 不過，數據顯示，中國獲批的許多腫瘤藥是一些已在美國上市一段時間藥物的中國本土版本。在將同類首創藥物推向市場方面，美國仍占據主導地位。...
Open in Who Shared Issue with article?

Кина одобрила повеќе нови лекови против рак одошто САД

|
By Anna Edney Verified
| Bloomberg Adria Verified
Кинеските здравствени власти одобриле повеќе нови лекови за третман на канцер од нивните американски колеги во последните неколку години, според студија објавена во понеделник, која покажува дека инвестициите во кинеската биотехнолошка индустрија ја зголемуваат нејзината конкурентност на глобално ниво.
Open in Who Shared Issue with article?

Cancer Drug Approvals in China Outpace Those in US, Study Finds

|
By Anna Edney Verified
| Bloomberg Law Verified
Chinese health authorities approved more novel cancer drugs than their US counterparts in the last several years, according to a study published Monday that shows investments in China’s biotechnology industry are enhancing its competitiveness globally. Between 2020 and 2025, China’s National Medical Products Administration cleared 94 novel oncology drugs for sale compared with 87 green lit by the .
Open in Who Shared View Duplicates (3) Issue with article?
See all 2,514 licensed articles (3,823 Total)